CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply chains, not just within the United States but worldwide. With the re-introduction of Trump-era tariffs on key goods, companies engaged in clinical research must rethink their sourcing and logistics strategies. Clinical Services International (CSI) is proactively addressing these challenges to support our clients amid this uncertain climate. Wh

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a GLP-1 receptor agonist, as a comparator drug. The study spanned multiple regions, including North America, Europe, and Asia-Pacific. This required a consistent and compliant supply of the drug across various regulatory landscapes. The sponsor needed a reliable partner to source Semaglutide efficiently while ensuring batch consistency, Certifi

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together clinical supply professionals from around the world to discuss industry trends, challenges and strategies for your clinical trial pipeline. CSI’s Managing Director, Vanessa Dekou, hosted a successful and sell-out workshop at GCSG US, to share over 25 years’ worth of expert insights on the complexities of comparator sourcing strategies. If yo

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a Phase II ophthalmology clinical trial. This project demanded precise planning and timely execution. It was crucial to ensure an uninterrupted supply across multiple global sites. The client prioritized batch consistency and Certificates of Analysis (CoA) for all supplies. Understanding the Challenges The biotech company faced several hurdles in

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

Request: CSI was tasked with sourcing a vast quantity of Venetoclax and Azacitidine for a large pharmaceutical company's global study on...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine! This recognition is not only a personal achievement but a testament to the incredible work of the Clinical Services International team. We have been driving excellence in clinical trial services, making a real impact to clinical research and patients lives. Read the Life Sciences Review article here.

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight and coordination of all activities involved in the sourcing, packaging, distribution and management of clinical trial comparator drugs and ancillaries. The goal is to ensure that these materials are available at the right place, at the right time, in the right condition, and in the correct quantities, all while complying with regulatory req

Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

Learn more about local comparator sourcing and the advantages it can bring to clinical trials Comparators are increasingly being used in...

Here are four ways CSI maintains quality assurance in clinical trial supply Maintaining quality throughout a clinical trial is an ongoing...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more specific to tumour or cell pathologies and increasing patient numbers. Several oncology products now have ‘blockbuster’ status where sales exceed $1 billion annually. This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster produc